Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 4 opinions in the last 12 months.
SABESP (SBS-N) has consistently been highlighted as a top investment choice by several analysts due to its strong positioning in Brazil’s water treatment and sanitation sector. The reviews emphasize its avoidance of tariff-related disruptions, geographic diversification, and robust financial metrics such as impressive return on equity (ROE) figures, which hover around 27-28%. The stock is noted for its attractive valuation, trading at multiples that reflect earnings and book values favorably compared to its sector. Furthermore, analysts suggest various price targets ranging from $20 to $23.85, indicating an upside potential of 23% to over 30%. The stock also provides a modest yield, appealing to both growth and income-focused investors.
(A Top Pick June 12/12. Down 19.53%.) Water utility company in São Paulo. Stock has been absolutely hammered by the political turmoil that is going on in Brazil and the weakness in the Brazilian dollar. Brazil is a place you want to avoid for a little bit. This is a good stock to own. 5X earnings. Nice dividend yield.
SABESP is a American stock, trading under the symbol SBS-N on the New York Stock Exchange (SBS). It is usually referred to as NYSE:SBS or SBS-N
In the last year, there was no coverage of SABESP published on Stockchase.
SABESP was recommended as a Top Pick by on . Read the latest stock experts ratings for SABESP.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered SABESP In the last year. It is a trending stock that is worth watching.
On 2025-04-17, SABESP (SBS-N) stock closed at a price of $18.72.
We reiterate this Brazil based water treatment utility as a TOP PICK. It has avoided much of the tariff related mayhem thus far and provides some geographic diversification. It trades at 15x earnings, 1.7x book and supports a 28% ROE. We recommend scaling up the stop (from $14) to $16, looking to achieve $23 -- upside potential over 30%.
(Analysts’ price target is $23.85)